Clinical Trials Logo

Filter by:
  • Withdrawn  
  • « Prev · Page [14]
NCT ID: NCT00003984 Withdrawn - Clinical trials for Myelodysplastic Syndromes

Monoclonal Antibody Therapy in Treating Patients With Primary Myelodysplastic Syndrome

Start date: February 1999
Phase: Phase 2
Study type: Interventional

RATIONALE: Monoclonal antibodies can locate tumor cells and either kill them or deliver tumor-killing substances to them without harming normal cells. PURPOSE: Phase II trial to study the effectiveness of monoclonal antibody therapy in treating patients who have primary myelodysplastic syndrome.

NCT ID: NCT00003979 Withdrawn - Clinical trials for Unspecified Adult Solid Tumor, Protocol Specific

CHS 828 in Treating Patients With Solid Tumors

Start date: April 1999
Phase: Phase 1
Study type: Interventional

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of CHS 828 in treating patients who have solid tumors.